Share This

Create Your Own Business Intelligence Website   Input the stock code or the company name     Search   <01672.HK> - ASCLETIS PHARMA INC.    Stock Screener：Biotechnology, Biotechnology HUTCHMED INNOVATIVE PHAR UNI-BIO GROUP KING INTL INV BBI LIFE SCI ESSEX BIO-TECH JACOBIO-B CANBRIDGE-B 3D MEDICINES FUDANZHANGJIANG OCUMENSION-B FRONTAGE 3SBIO IMMUNEONCO-B GENSCRIPT BIO INNOVENT BIO VIVA BIOTECH TOT BIOPHARM-B JUNSHI BIO EVEREST MED-B LAEKNA-B JW THERAP-B BRII-B HBM HOLDINGS-B LEPU BIO-B KEYMED BIO-B BASECARE-B CARSGEN-B RECBIO-B MABPHARM-B CLOVER BIO-B ABBISKO-B SIRNAOMICS-B WUXI XDC WUXI BIO BIOCYTOGEN-B MEILLEUREHEALTH WUXI APPTEC GIANT BIOGENE LUZHU BIOTECH-B CUTIA-B YZYBIO-B QYUNS-B HIGHTIDE-B HUA MEDICINE-B CSTONE PHARMA-B HENLIUS TIGERMED SINOMAB BIO-B CT ENTERPRISE AUSTAR JOINN BEIGENE CANSINOBIO SCICLONE PHARMA TRANSCENTA-B AIM VACCINE MEGA GENOMICS HAOHAI BIOTEC ASCENTAGE-B BOAN BIOTECH IMMUNOTECH-B SKB BIO-B ANTENGENE-B GENOR-B HAO WEN HLDGS HK LIFE SCI CRMI PFC DEVICE BIOSINO BIO-TEC NEP INTERLONG CORNERSTONE TEC HUAKANG BIOMED    Basic Datum Company name Lot P/E P/B EPS DPS ASCLETIS-B 1000 -9.89 0.5307 -0.1477 0.0 Profile Information Data Financial Ratios Profit Loss Cash Flow Balance Earnings Dividend    Related links    Related news    歌禮-B停止多項FXR激動劑ASC42臨床試驗及研究   《公司業績》歌禮製藥全年虧損收窄至1.45億人民幣   歌禮製藥－Ｂ在美國皮膚病學會年會上展示治療痤瘡藥物研究結果   歌禮製藥-B完成治療痤瘡III期臨床試驗首例患者給藥   歌禮製藥-B(01672.HK)早段曾升逾11% ASC41...   歌禮製藥-B(01672.HK)肝炎藥ASC41片劑臨床試驗...  ≫More    Company Rating Date Broker Company name Rating Target ≫More    Company performance - Published Date Company name Turnover* Profit* % Dividend ≫More    Comment 2022-12-21　歌禮製藥（1672）周一晚宣布旗下口服新冠藥物收到美國專利與商標局（USPTO）的授權公告通知書，公告日期為2023年1月3日。歌禮的口服病毒聚合酶抑制劑ASC10和衍生物可用於治療新冠病毒、猴痘病毒及人呼吸道合胞病毒（RSV）。      Top Gain / Loss Show All Charts     Value Name Updated Value Change Change % HSI 04-17 13:02 16231.6 ▼ 17.33 ▼ 0.11% ASCLETIS-B 04-19 16:08 1.28 ▲ 1.28 ▲ ∞% ≫More

Mobile | Full

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map

Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved

Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.